<unk>  is a alpha1A adrenoceptor agonist that is FDA approved for the topical treatment of persistent facial erythema associated with rosacea in adults.   Common adverse reactions include application site dermatitis, worsening inflammatory lesions of rosacea, application site pruritis, application site erythema, and application site pain.
Oxymetazoline hydrochloride
Moxaverine
Tolazoline
Tymazoline
Xylometazoline
Imidazoline
Tramazoline
Naphazoline